(PRWEB) October 6, 2004
A new clinical study in Osteoarthritis using Hako-MedsÂ patented Horizontal Therapy was one of three research papers on Horizontal Therapy published two weeks ago at the national annual congress of the Italian Society of Physical Medicine and Rehabilitation in Italy. This latest clinical data demonstrates long-term effects unprecedented with any treatment option for Osteoarthritis.
After approximately ten treatments one hundred percent of the two hundred subjects in the study had completely discontinued their pain medications. Follow-up at three and six months without further Horizontal Therapy treatments demonstrated a significant percentage of subjects who have not reverted to using medications.
Horizontal Therapy is a noninvasive pleasant treatment without any negative side effects. Positive therapeutic results in up to ninety percent of all patients are immediate, significant and cumulative.
Horizontal Therapy is currently available in the United States from a variety of physician specialties. Hako-Med possesses market clearance for pain as well as other indications.
Horizontal Therapy uses a specialized patented form of bioelectricity different from conventional Electromedicine which presents Horizontal Therapy as a viable alternative to potentially dangerous pharmaceuticals in the treatment of pain.
For more information, additional clinical papers, available translations and/or interview requests please contact Kai HansjÃ¼rgens at 1-888-913-7900 ext 21.
# # #